NCT00033189View on ClinicalTrials.gov

An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular Dystrophy

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2001

Study Completion Date

January 31, 2005

Conditions
Muscular Dystrophy, Duchenne
Interventions
DRUG

Coenzyme Q10

Trial Locations (2)

20010

Children's National Medical Center, Washington D.C.

63110

Washington University-St. Louis, St Louis

All Listed Sponsors
lead

Cooperative International Neuromuscular Research Group

NETWORK

NCT00033189 - An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular Dystrophy | Biotech Hunter | Biotech Hunter